Evelo Biosciences's total assets for Q3 2023 were $20.63M, a decrease of -0.92% from the previous quarter. EVLO total liabilities were $47.33M for the fiscal quarter, a -29.29% a decrease from the previous quarter. See a summary of the company’s assets, liabilities, and equity.